Internacional

Dassault Systèmes in talks to buy drug trial software company for about $2bn

Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences

Por Redacción Sinergia Empresarial · 16 de julio de 2026 · 1 min
Dassault Systèmes in talks to buy drug trial software company for about $2bn

Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences

Sinergia Empresarial continuará el seguimiento de esta información sobre dassault Systèmes in talks to buy drug trial software company for about $2bn y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.